Revista Chilena de Neuro-Psiquiatria最新文献_第9页

El impacto de la resiliencia en la esquizofrenia: una revisión sistemática cualitativa. 复原力对精神分裂症的影响：一项定性系统回顾。

Revista Chilena de Neuro-Psiquiatria Pub Date : 2022-03-01 DOI: 10.4067/s0717-92272022000100075

Álvaro Araya, N. González, J. Vallejos, Sergio Ruiz

引用次数: 0

Déficits neuropsicológicos en mujeres con trastornos de la conducta alimentaria 饮食行为障碍妇女的神经心理缺陷

Revista Chilena de Neuro-Psiquiatria Pub Date : 2022-03-01 DOI: 10.4067/s0717-92272022000100040

María José Bracho P, Aitana Grasso-Cladera, Christian Salas R

{"title":"Déficits neuropsicológicos en mujeres con trastornos de la conducta alimentaria","authors":"María José Bracho P, Aitana Grasso-Cladera, Christian Salas R","doi":"10.4067/s0717-92272022000100040","DOIUrl":"https://doi.org/10.4067/s0717-92272022000100040","url":null,"abstract":"Background: Anorexia nervosa (AN) and bulimia nervosa (BN) are severe and chronic mental health illnesses that affect a high percentage of the population. A growing number of studies have reported neuropsychological impairments in this population, apparently contributing to the onset and progression of the disorder, and impacting on treatment efficacy and recovery. Methodology: This Narrative Review aimed to summarize findings regarding the neuropsychological profile of women with AN and BN at different treatment phases. Results: Available evidence suggests that women with AN and BN present a profile of executive and social cognition deficits. These results are consistent with evidence from neuroimaging findings of structural brain alterations in frontal areas and frontal-subcortical circuits. Conclusions: Knowledge about the neuropsychological profiles of AN and BN women offers key information to understand the clinical presentation of this population and challenges in adhering and benefiting from treatment. Future studies should explore the efficacy of interventions targeting neuropsychological impairments and how they contribute to treatment as usual.","PeriodicalId":39300,"journal":{"name":"Revista Chilena de Neuro-Psiquiatria","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46388393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Desensibilización y reprocesamiento por movimientos oculares (EMDR) para trastornos ansiosos y depresivos en niños y adolescentes: revisión de la evidencia disponible. 儿童和青少年焦虑和抑郁障碍的眼动脱敏和再处理(EMDR):现有证据综述。

Revista Chilena de Neuro-Psiquiatria Pub Date : 2022-03-01 DOI: 10.4067/s0717-92272022000100051

María Ignacia Retamal, Elisa Sepúlveda, J. Cortés, F. Barraza, M. Arancibia

引用次数: 0

Síndrome de la mano inútil con astereognosia secundaria a un astrocitoma cervical. 宫颈星形细胞瘤继发的无手综合征伴星号。

Revista Chilena de Neuro-Psiquiatria Pub Date : 2022-03-01 DOI: 10.4067/s0717-92272022000100124

F. Vergara, T. Ramos, Nicolás Rebolledo, S. Soto

引用次数: 0

Quiste aracnoideo (Galassi Tipo II) y síntomas neuropsiquiátricos: a propósito de un caso. 蛛网膜囊肿（Galassi II型）和神经精神症状：一例。

Revista Chilena de Neuro-Psiquiatria Pub Date : 2022-03-01 DOI: 10.4067/s0717-92272022000100116

Jesús Amador L., Sandra González A., Lorys Osses, Alvino De León, G. González

{"title":"Quiste aracnoideo (Galassi Tipo II) y síntomas neuropsiquiátricos: a propósito de un caso.","authors":"Jesús Amador L., Sandra González A., Lorys Osses, Alvino De León, G. González","doi":"10.4067/s0717-92272022000100116","DOIUrl":"https://doi.org/10.4067/s0717-92272022000100116","url":null,"abstract":"Introduction: an arachnoid cyst is caused by the alteration of one of the membranes of the meninges (arachnoid), predominantly in the middle cranial fossa; It is an uncommon pathology that causes symptoms and if they occur, neuropsychiatric manifestations may take place. Objective: expose the clinical data; and the diagnostic and therapeutic methodology. Case: we present a 24-year-old female patient; with no personal history of psychiatric and known non-psychiatric medical records, whom presents a story with a month of evolution of psychotic symptoms and behavioral changes. A simple cerebral CAT was performed and then a cerebral magnetic resonance imaging with contrast to define the size of the arachnoid cyst, due to the possible neuropsychiatric symptoms found. Through laboratory tests, electrophysiological studies (electroencephalogram), neuroimaging and clinical evaluation. It was decided to present the clinical characteristics of the patient who required management with antipsychotics, benzodiazepines and mood stabilizer with gradual improvement of her admission symptoms (psychomotor agitation and psychosis)","PeriodicalId":39300,"journal":{"name":"Revista Chilena de Neuro-Psiquiatria","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47500785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Consenso Chileno Para el Diagnóstico y Tratamiento De Gliomas del Adulto 智利对成人胶质瘤诊断和治疗的共识

Revista Chilena de Neuro-Psiquiatria Pub Date : 2022-03-01 DOI: 10.4067/s0717-92272022000100102

Mariana Sinning O, Ariel Fariña B, Raúl Valenzuela M, Carlos Bennett C, Rodrigo Riveros P, Francisco Torres, P. Paredes M, Roger Gejman E, Ronny Muñoz M, Juvenal A. Ríos

{"title":"Consenso Chileno Para el Diagnóstico y Tratamiento De Gliomas del Adulto","authors":"Mariana Sinning O, Ariel Fariña B, Raúl Valenzuela M, Carlos Bennett C, Rodrigo Riveros P, Francisco Torres, P. Paredes M, Roger Gejman E, Ronny Muñoz M, Juvenal A. Ríos","doi":"10.4067/s0717-92272022000100102","DOIUrl":"https://doi.org/10.4067/s0717-92272022000100102","url":null,"abstract":"Brain tumors are characterized by high morbidity and mortality. The vast majority correspond to secondary tumors (metastasis). On the other hand, within the primary tumors of the central nervous system, gliomas correspond to 30% of these. In the US, between 2007-2011, an approximate incidence of 21.4 cases per 100,000 inhabitants was estimated. Recent advances in the molecular understanding of the biology of these tumors have made it possible to substantially improve their classification, allowing a better correlation with clinical outcomes and prognosis. Along these lines, today, it is possible to stratify patients by risk and deliver treatments capable of prolonging global survival between 5-7 years, for grade II and III gliomas. The present consensus, prepared by a multidisciplinary panel of experts from various Chilean scientific societies and, therefore, from all the specialties involved in the medical and surgical therapy. Enlightened from the molecular oncology, this proposal offers an input of clinical utility, which, together with an updated review in relation to the treatment and follow-up of these patients, allows us to understand the relevance of these biomarkers in precision disease management. It should be noted that this manuscript emerges from the same work force, which prepared the Clinical Protocol for Adult Gliomas 2019, published by the Ministry of Health, and that differs from it, which offers clinical-operative details, such as flowcharts and dose, our review attempts to reveal imaging and molecular advances and how they impact the current management of the disease.","PeriodicalId":39300,"journal":{"name":"Revista Chilena de Neuro-Psiquiatria","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45236638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Trauma y Amnesia Disociativa: La visión de Pierre Janet. 创伤与分离性失忆症:皮埃尔·珍妮特的观点。

Revista Chilena de Neuro-Psiquiatria Pub Date : 2022-03-01 DOI: 10.4067/s0717-92272022000100092

Armando Nader N.

引用次数: 0

Cefalea por abuso de medicamentos y sus marcadores clínicos 药物滥用头痛及其临床标志物

Revista Chilena de Neuro-Psiquiatria Pub Date : 2022-03-01 DOI: 10.4067/s0717-92272022000100026

Nelson Barrientos U., Raúl Juliet P., Alan Rapoport, Philipe Salles G, Anna Milán S., Paulina Meza C.

{"title":"Cefalea por abuso de medicamentos y sus marcadores clínicos","authors":"Nelson Barrientos U., Raúl Juliet P., Alan Rapoport, Philipe Salles G, Anna Milán S., Paulina Meza C.","doi":"10.4067/s0717-92272022000100026","DOIUrl":"https://doi.org/10.4067/s0717-92272022000100026","url":null,"abstract":"Introduction: Clinical markers of medication overuse headache (MOH) are based on headache classification developed by the International Headache Society (IHS). This classification include only two criteria: frequency of headache days must be 15 or more days per month for at least three or more months; and the number of days of overuse medication must be either 10 or 15 days per month depending on the type of medication. However, patients often have others distinct associated clinical markers, which are overlooked by most physicians during the initial evaluation. Methodology: This study is a prospective, longitudinal and observational study of 76 patients admitted to DIPRECA ́s hospital Headache Unit. They were all diagnosed with, MOH according to the criteria established by the his ICHD III beta.(1) Patients were given standard treatment including detoxification and preventive medications and followed for 6 months. Symptoms of interest were recorded in at each clinical monitoring visit and assessment scales such as Zung, MIDAS, HIT-6 were administered. Results: Overused medications included nonsteroidal anti-inflammatory drugs (NSAIDs), triptans and ergots. The most significant clinical symptoms associated were: awaking in the morning with headache, awaking the patient at dawn by headache, attention difficulties, depression, cervical pain and myofascial pain syndrome. All symptoms significantly improved when treatment began, as did quality of life as measured by MIDAS and HIT-6 scales. Discussion: In evaluating patients with MOH consider both the ICHD III beta diagnostic criteria and the common and specific symptoms seen in most cases of MOH.","PeriodicalId":39300,"journal":{"name":"Revista Chilena de Neuro-Psiquiatria","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44800663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Asociación Entre Enfermedades Cardiometabólicas y Depresión En Un Hospital De Referencia Peruano 秘鲁一家参考医院心脏代谢疾病与抑郁症的关系

Revista Chilena de Neuro-Psiquiatria Pub Date : 2022-03-01 DOI: 10.4067/s0717-92272022000100013

A. L. Núñez-Muñoz, A. Soto, J. D. Roca-Sánchez-Moreno, D. M. Quiñones-Laveriano, S. Indacochea-Cáceda, J. D. L. Cruz-Vargas

引用次数: 0

Desarrollo y estudio psicométrico de la Escala de Susceptibilidad al Castigo Anticipado (ESCA) 提前惩罚易感性量表的编制和心理测量学研究

Revista Chilena de Neuro-Psiquiatria Pub Date : 2021-12-01 DOI: 10.4067/s0717-92272021000400269

Ferran Padrós B., María Elena Guzmán B.

引用次数: 0